New treatment option for Knee Osteoarthritis
Official title Effect of iPACK and BiFeS Blocks on Quality of Recovery After Total Knee Arthroplasty
ClinicalTrials.gov ID: NCT07248072
What this study is testing
- What it's testing
- This prospective, randomized, double-blind clinical trial aims to compare the effects of two different posterior knee analgesia techniques-iPACK block (Interspace Between the Popliteal Artery and the Capsule of the posterior Knee) and the Biceps Femoris Short Head (BiFeS) block-when combined with an adductor canal block (ACB) in patients undergoing elective unilateral total knee arthroplasty (TKA). Effective postoperative analgesia is essential for early mobilization, enhanced recovery, and patient satisfaction after TKA.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age 18-75 years
- Scheduled for elective primary unilateral total knee arthroplasty (TKA)
- Planned spinal anesthesia
- ASA physical status I-III
- Ability to understand study procedures and provide written informed consent
You likely can't join if
- Known allergy or hypersensitivity to local anesthetics or other study medications
- Coagulopathy or current anticoagulant therapy
- Severe hepatic, renal, or cardiac failure
- History of neuropathic pain
- Infection at the site of proposed nerve block
- Pre-existing neuromuscular disorders in the lower extremities
See the full eligibility criteria
- Age 18-75 years
- Scheduled for elective primary unilateral total knee arthroplasty (TKA)
- Planned spinal anesthesia
- ASA physical status I-III
- Ability to understand study procedures and provide written informed consent
- Known allergy or hypersensitivity to local anesthetics or other study medications
- Coagulopathy or current anticoagulant therapy
- Severe hepatic, renal, or cardiac failure
- History of neuropathic pain
- Infection at the site of proposed nerve block
- Pre-existing neuromuscular disorders in the lower extremities
- Inability to cooperate or refusal to participate in the study
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Erzurum, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzurum, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.